the quarterly for PAA was interesting from a BIT perspective in that big pharma seem to have re-openned their doors and have time to engage again.
That was the big issue with progress for BIT at the end of last yr.
hmmmm.
Ann: Quarterly Activities Report, page-27
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
